These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10382887)

  • 1. Bismuth-mediated disruption of the glycocalyx-cell wall of Helicobacter pylori: ultrastructural evidence for a mechanism of action for bismuth salts.
    Stratton CW; Warner RR; Coudron PE; Lilly NA
    J Antimicrob Chemother; 1999 May; 43(5):659-66. PubMed ID: 10382887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ranitidine bismuth citrate on Helicobacter pylori motility, morphology and survival.
    Worku ML; Sidebotham RL; Karim QN
    Aliment Pharmacol Ther; 1999 Jun; 13(6):753-60. PubMed ID: 10383504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies.
    Ottlecz A; Romero JJ; Hazell SL; Graham DY; Lichtenberger LM
    Dig Dis Sci; 1993 Nov; 38(11):2071-80. PubMed ID: 8223083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterisation of bismuth(III) aminoarenesulfonate complexes and their powerful bactericidal activity against Helicobacter pylori.
    Busse M; Trinh I; Junk PC; Ferrero RL; Andrews PC
    Chemistry; 2013 Apr; 19(17):5264-75. PubMed ID: 23536213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histochemical tracing of bismuth in Helicobacter pylori after in vitro exposure to bismuth citrate.
    Stoltenberg M; Martiny M; Sørensen K; Rungby J; Krogfelt KA
    Scand J Gastroenterol; 2001 Feb; 36(2):144-8. PubMed ID: 11252405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kill kinetics of antimicrobial agents against Helicobacter pylori.
    Flamm RK; Beyer J; Tanaka SK; Clement J
    J Antimicrob Chemother; 1996 Oct; 38(4):719-25. PubMed ID: 8937967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation.
    Bland MV; Ismail S; Heinemann JA; Keenan JI
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1983-8. PubMed ID: 15155188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of soluble haemagglutinins on adherence of Helicobacter pylori to HEp-2 cells.
    Armstrong JA; Cooper M; Goodwin CS; Robinson J; Wee SH; Burton M; Burke V
    J Med Microbiol; 1991 Mar; 34(3):181-7. PubMed ID: 2010909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori.
    Ge R; Sun X; Gu Q; Watt RM; Tanner JA; Wong BC; Xia HH; Huang JD; He QY; Sun H
    J Biol Inorg Chem; 2007 Aug; 12(6):831-42. PubMed ID: 17503094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.
    Coudron PE; Stratton CW
    Antimicrob Agents Chemother; 1995 Jan; 39(1):66-9. PubMed ID: 7695331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel bismuth compounds have in vitro activity against Helicobacter pylori.
    Midolo PD; Norton A; von Itzstein M; Lambert JR
    FEMS Microbiol Lett; 1997 Dec; 157(2):229-32. PubMed ID: 9435101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate.
    Chen R; So MH; Yang J; Deng F; Che CM; Sun H
    Chem Commun (Camb); 2006 Jun; (21):2265-7. PubMed ID: 16718324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori.
    Nazari P; Dowlatabadi-Bazaz R; Mofid MR; Pourmand MR; Daryani NE; Faramarzi MA; Sepehrizadeh Z; Shahverdi AR
    Appl Biochem Biotechnol; 2014 Jan; 172(2):570-9. PubMed ID: 24104691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.
    Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Scand J Gastroenterol; 1994 Jun; 29(6):528-31. PubMed ID: 8079111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional disruption of HypB, a GTPase of Helicobacter pylori, by bismuth.
    Xia W; Li H; Sun H
    Chem Commun (Camb); 2014 Feb; 50(13):1611-4. PubMed ID: 24389922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of substances inhibiting or uncoupling respiratory-chain phosphorylation of Helicobacter pylori.
    Baer W; Koopmann H; Wagner S
    Zentralbl Bakteriol; 1993 Sep; 280(1-2):253-8. PubMed ID: 8280949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Bismuth in the Eradication of Helicobacter pylori.
    Alkim H; Koksal AR; Boga S; Sen I; Alkim C
    Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The susceptibility of Helicobacter pylori to 12 antimicrobial agents, omeprazole and bismuth salts.
    Rubinstein G; Dunkin K; Howard AJ
    J Antimicrob Chemother; 1994 Sep; 34(3):409-13. PubMed ID: 7829415
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.
    Vogt K; Rodloff AC; Hahn H
    Infection; 1991; 19(3):138-9. PubMed ID: 1832417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.